Healthcare Industry News: AGA Medical
News Release - October 2, 2014
EarlySense Welcomes Mr. John Barr as a New Member to the Board of DirectorsRAMAT GAN, Israel, October 2, 2014 -- (Healthcare Sales & Marketing Network) --EarlySense®, the market leader in contact-free monitoring solutions announced today that Mr. John Barr, medical device executive and industry expert has joined the company's board of directors.
"John has remarkable business expertise, and we are delighted that he is joining EarlySense's board of directors," said Avner Halperin, CEO of EarlySense Ltd. "John's experience in leading companies to major commercial success will assist us in creating significant corporate value and advance partnerships with major players in the industry."
Mr. John R. Barr has led some innovative and successful medical device companies. He was most recently Executive Vice President and President of Global Surgical at Bausch & Lomb Holdings Incorporated until the acquisition of Bausch and Lomb by Valeant Pharmaceuticals in 2013. Prior to Bausch and Lomb, Barr was the CEO of AGA Medical, pioneer and leader in minimally invasive devices to repair structural heart defects and other vascular defects. Mr. Barr led an IPO for the Company in 2009 and the business was sold to St. Jude Medical in 2010.
Mr. Barr is a graduate of the J. L. Kellogg Graduate School of Management-Northwestern University where he earned his Master's degree in finance, accounting and economics. He earned his undergraduate degree in bioengineering from the University of Pennsylvania.
"I am excited to join other industry leaders on EarlySense's board." Barr said. "Earlysense is well positioned to become a game changer in the monitoring market for hospitals as well as long term care and home settings. I look forward to helping the company grow rapidly. The company has done a great job to date in proving the value of its technology and getting market traction. It is well poised now to become a standard of care contributing in millions of beds, contributing to patient safety, outcomes and enhancing care giver efficiency."
EarlySense, the market leader in Contact-free and Continuous patient monitoring, assists clinicians in early detection of patient deterioration and in identifying and preventing potential adverse events such as patient falls and pressure ulcers. The company's solutions monitor patient's heart and respiratory rate, as well as movement, with a unique sensor that is placed under the mattress. The system was designed to address safety challenges on general care floors as well as failure to rescue of those patients who are usually monitored by nursing staff approximately once every four to eight hours. EarlySense also offers OEM solutions for companies looking to expand their products by providing contact-free and continuous sensing capabilities.
EarlySense International headquarters is in Israel, and US headquarters is in Waltham, MA, the EarlySense System is currently installed in hospitals and rehabilitation centers in USA, Europe, Asia and Australia. For more information, visit EarlySense.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.